279 related articles for article (PubMed ID: 12490737)
21. Impact of Anemia in Patients With Head and Neck Cancer.
Kumar P
Oncologist; 2000 Jun; 5 Suppl 2():13-18. PubMed ID: 10889270
[TBL] [Abstract][Full Text] [Related]
22. Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients.
Nordsmark M; Eriksen JG; Gebski V; Alsner J; Horsman MR; Overgaard J
Radiother Oncol; 2007 Jun; 83(3):389-97. PubMed ID: 17499868
[TBL] [Abstract][Full Text] [Related]
23. [Radiosensitization of hypoxic tumor cells with special reference to head and neck cancers].
Kogelnik HD
Wien Klin Wochenschr; 1983 Aug; 95(15):515-8. PubMed ID: 6636784
[TBL] [Abstract][Full Text] [Related]
24. [Radioresistance parameters in head and neck cancers and methods to radiosensitize].
Biau J; Chautard E; Miroir J; Lapeyre M
Cancer Radiother; 2015 Aug; 19(5):337-46; quiz 360-1, 363. PubMed ID: 26119219
[TBL] [Abstract][Full Text] [Related]
25. Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy.
Hoff CM
Acta Oncol; 2012 Apr; 51(4):419-32. PubMed ID: 22313317
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia.
Arcasoy MO; Amin K; Chou SC; Haroon ZA; Varia M; Raleigh JA
Clin Cancer Res; 2005 Jan; 11(1):20-7. PubMed ID: 15671524
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
Koukourakis MI; Giatromanolaki A; Sivridis E; Pastorek J; Karapantzos I; Gatter KC; Harris AL;
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):67-71. PubMed ID: 15093900
[TBL] [Abstract][Full Text] [Related]
28. Anemia correction in malignancy management: threat or opportunity?
De Los Santos JF; Thomas GM
Gynecol Oncol; 2007 May; 105(2):517-29. PubMed ID: 17367848
[TBL] [Abstract][Full Text] [Related]
29. [Anemia in head and neck cancers].
Azria D; Zouhair A; Serre A; Lemanski C; Schneider M; Ozsahin M; Dubois JB; Lartigau E;
Bull Cancer; 2005 May; 92(5):445-51. PubMed ID: 15932808
[TBL] [Abstract][Full Text] [Related]
30. Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: results of a randomized clinical trial.
Haffty BG; Hurley R; Peters LJ
Cancer J Sci Am; 1999; 5(6):341-7. PubMed ID: 10606475
[TBL] [Abstract][Full Text] [Related]
31. Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.
Hu F; Vishwanath K; Salama JK; Erkanli A; Peterson B; Oleson JR; Lee WT; Brizel DM; Ramanujam N; Dewhirst MW
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):462-469. PubMed ID: 27598811
[TBL] [Abstract][Full Text] [Related]
32. Prognostic implications of hemoglobin levels before and after surgery as well as before and after radiochemotherapy for head and neck tumors.
Reichel O; Panzer M; Wimmer C; Dühmke E; Kastenbauer E; Suckfüll M
Eur Arch Otorhinolaryngol; 2003 May; 260(5):248-53. PubMed ID: 12750913
[TBL] [Abstract][Full Text] [Related]
33. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.
Dubray B; Mosseri V; Brunin F; Jaulerry C; Poncet P; Rodriguez J; Brugère J; Point D; Giraud P; Cosset JM
Radiology; 1996 Nov; 201(2):553-8. PubMed ID: 8888257
[TBL] [Abstract][Full Text] [Related]
34. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia.
Nakano T; Suzuki Y; Ohno T; Kato S; Suzuki M; Morita S; Sato S; Oka K; Tsujii H
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2185-90. PubMed ID: 16609033
[TBL] [Abstract][Full Text] [Related]
35. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
36. Oxygenation of human tumors--implications for combined therapy.
Feldmann HJ
Lung Cancer; 2001 Sep; 33 Suppl 1():S77-83. PubMed ID: 11576711
[TBL] [Abstract][Full Text] [Related]
37.
Qian Y; Von Eyben R; Liu Y; Chin FT; Miao Z; Apte S; Carter JN; Binkley MS; Pollom EL; Harris JP; Prionas ND; Kissel M; Simmons A; Diehn M; Shultz DB; Brown JM; Maxim PG; Koong AC; Graves EE; Loo BW
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1183-1192. PubMed ID: 29859786
[TBL] [Abstract][Full Text] [Related]
38. Raising hemoglobin: an opportunity for increasing survival?
Thomas GM
Oncology; 2002; 63 Suppl 2():19-28. PubMed ID: 12466641
[TBL] [Abstract][Full Text] [Related]
39. Role of anemia prior to radiation treatment in local recurrence and survival after breast conservation treatment for early-stage breast cancer.
Harris EE; Kasi S; Hwang WT; Vapiwala N; Solin LJ
Clin Breast Cancer; 2010 Feb; 10(1):74-80. PubMed ID: 20133262
[TBL] [Abstract][Full Text] [Related]
40. [Radiation sensitizers: with special reference to hypoxic cell sensitizers].
Onoyama Y; Nakajima T; Tanaka M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):894-903. PubMed ID: 3963856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]